MECHANISM OF ACTIVATION OF PLATELET GPIIB AND GPIIIA
MECHANISM OF ACTIVATION OF PLATELET GPIIB AND GPIIIA
批准号:
2910658
负责人:
Jeffrey W Smith
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 2002-04-30
关键词:
SDS polyacrylamide gel electrophoresis affinity chromatography calpain chemical association chemical kinetics conformation cytoplasm divalent cations enzyme linked immunosorbent assay epidermal growth factor epitope mapping fibrinogen receptors high performance liquid chromatography integrins ligands mass spectrometry molecular site peptide library platelet activation protein binding protein purification protein sequence protein structure function proteolysis western blottings
中文摘要
本研究的长期目标是了解心力衰竭的机制。
活化血小板整合素GPIIb-IIIa。GPIIb-IIIa是
血小板黏附和聚集。对其规制的一种理解
可能对治疗许多心血管疾病很重要
包括心肌梗塞和中风。上存在GPIIb-IIIa
处于休眠状态的血小板不能结合可溶性的
纤维蛋白原。在血小板刺激下,IIb-IIIa变得能够
结合纤维蛋白原和介导血小板聚集。虽然
IIb-IIIa激活是血小板功能的关键,其机制
激活问题尚未解决。
这项研究的一个假设是,蛋白水解性切割
IIb-IIIa的胞质结构域控制着细胞的激活状态
整合素。这一假设将通过刻画
两种纯化形式胞质结构域的结构差异
激活状态不同的IIb-IIIa。
这项研究的第二个目标是了解
激活依赖的配体与IIb-IIIa结合。噬菌体展示将是
用于选择优先与休眠和
整合素的活性形式。这项研究的结果可能会
提供解释依赖于激活的结构-活动系列
配基结合。
这项研究的第三个目标是了解
整合素激活。激活是由配体的增加引起的吗
缔合率还是配体解离率的降低?这些
研究将在全血小板上进行,并使用纯化形式的
休眠和活跃的IIb-IIIa。
最终目标是了解IIb上的二价离子结合位点是如何-
IIIA影响激活事件。将进行约束性研究
钙与休眠和活性IIb-IIIa的纯化构象之间的关系。
这一分析的结果应该确定哪一类离子结合
结合位点调节整合素的激活。
英文摘要
The long term objective of this study is to understand the mechanism of
activation of the platelet integrin GPIIb-IIIa. GPIIb-IIIa is key to
platelet adhesion and aggregation. An understanding of its regulation
is likely to be important for treating many cardiovascular diseases
including myocardial infarction and stroke. GPIIb-IIIa exists on
resting platelets in a dormant conformation unable to bind soluble
fibrinogen. Upon platelet stimulation, IIb-IIIa becomes capable of
binding fibrinogen and mediating platelet aggregation. Although
activation of IIb-IIIa is key to platelet function, the mechanism its
activation has not been solved.
One hypothesis of the study is that proteolytic cleavage of the
cytoplasmic domains of IIb-IIIa control the activation state of the
integrin. This hypothesis will be tested by characterizing the
structural differences in the cytoplasmic domain of two purified forms
of IIb-IIIa which differ in activation state.
A second goals of the study is to understand the structural basis of
activation-dependent ligand binding to IIb-IIIa. Phage-display will be
used to select ligands that bind preferentially to the dormant and
active forms of the integrin. Results from this study are likely to
provide a structure-activity series explaining activation-dependent
ligand binding.
A third aim of the study is to understand the kinetic aspects of
integrin activation. Does activation result from an increase in ligand
association rate or a decrease in ligand dissociation rate? These
studies will be performed on whole platelets and with purified forms of
dormant and active IIb-IIIa.
A final goal is to understand how the divalent ion binding sites on IIb-
IIIa influence the activation event. Binding studies will be performed
between Ca2+ and purified conformers of dormant and active IIb-IIIa.
Results from this analysis should determine which class of ion binding
sites regulate activation of the integrin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE D - Proteomics Core
-
批准号:10475596
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
CORE D - Proteomics Core
-
批准号:10171427
-
项目类别:
-
资助金额:$60.76万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
De-orphanizing MMPs in intercelluar interactions
-
批准号:9176901
-
项目类别:
-
资助金额:$52.24万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
CORE D - Proteomics Core
-
批准号:10641845
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
Core D: Proteomics Core Facility
-
批准号:9072752
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
Systems biology of glutamine utilization in melanoma
-
批准号:8624405
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2014
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:8230593
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:8447042
-
项目类别:
-
资助金额:$48.33万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:8050696
-
项目类别:
-
资助金额:$50.53万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:7890649
-
项目类别:
-
资助金额:$52.17万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:8507168
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:7657217
-
项目类别:
-
资助金额:$57.13万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
Project 3: MITF in Drug Resistance and Metabolism in Melanoma
-
批准号:9071970
-
项目类别:
-
资助金额:$42.88万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:8267705
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:8081763
-
项目类别:
-
资助金额:$48.4万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
CENTER ON PROTEOLYTIC PATHWAYS(RMI)
-
批准号:7961277
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 6 : PROJECT LEADERSHIP AND ADMINISTRATION
-
批准号:7725969
-
项目类别:
-
资助金额:$152.92万
-
财政年份:2008
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 1 TRP2: PROTEASE ACTIVITY IMAGING TECHNOLOGY (PAIT)
-
批准号:7725955
-
项目类别:
-
资助金额:$35.24万
-
财政年份:2008
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 2 DB2: PROTEOLYTIC REGULATION OF HIF-1ALPHA
-
批准号:7725959
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2008
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 2 DB2: PROTEOLYTIC REGULATION OF HIF-1ALPHA
-
批准号:7622857
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2007
-
负责人:Jeffrey W Smith
-
依托单位:
海外基金